What are the key competitors & why? How are they differentiated? What is the level of threat?

Analysis of current/future clinical practice & marketplace, characterisation of unmet needs, opportunities & strategic drivers

  • What are the main competitors from a mechanistic and/or disease segment perspective?
  • What is known about their profiles and development plan?
  • What is the level of threat from each competitor? How are the competitors differentiated?
  • What impact will the competition have on the future treatment landscape?
  • Which competitor companies represent the highest threat in a disease/disease segment?




Posted in: Disease Area